Spit, swab, drop DNA in the mail. This month, physicians, researchers, and medical ethicists discuss the clinical utility, potential risks, and ethical considerations of direct-to-consumer genetic testing.
Is the drug trial landscape about to change? DW explores the reasons why children have been left out of drug studies, the legislative and regulatory frameworks in place, and the progress that is being made in pediatric drug testing.
In an ideal world, physicians could access patients’ health information from other doctors with the click of a button. But medicine isn’t quite there yet. This month, experts discuss the current status of EHR interoperability initiatives.
Use these basics to build the perfect practice website.
Get started with social media — or take your online presence to the next level.
When insurance doesn’t cover standard of care treatments, who pays the price?
Experts offer advice on emergency preparedness planning for your practice.
How has dermatology changed over the last 40 years?
A visual guide to private equity’s presence within the specialty.
Meeting patients’ desire for alternative medicine with evidence-based care.
With the introduction of the ‘copay accumulator,’ the battle between insurers and drug makers has escalated.
It’s the last quarter of MIPS performance year 2019: Do you have a game plan?
Alex Miller, MD, offers a modifier 25 refresher.
Peering through the haze of medical marijuana laws.
Diagnosing and managing delusional parasitosis.